Pharma Mar S.A. (PHM) — Cash Flow Reinvestment Rate

Latest as of December 2025: 1.74x

Pharma Mar S.A. (PHM) has a Cash Flow Reinvestment Rate of 1.74x as of December 2025, reinvesting €58.27 Million (capex €6.26 Million plus investments €-52.01 Million) from operating cash flow of €33.58 Million. Check Pharma Mar S.A. (PHM) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

1.74x

(Capex + Investments) / Operating CF

Total Reinvested

€58.27 Million

Capex + Investments

Operating Cash Flow

€33.58 Million

EUR

Capital Expenditures

€6.26 Million

EUR

Pharma Mar S.A. Cash Flow Reinvestment Rate (2012–2025)

Historical reinvestment intensity for Pharma Mar S.A. across 9 annual periods. Explore Pharma Mar S.A. (PHM) long-term investment share to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Pharma Mar S.A. (2012–2025)

Year-by-year capital reinvestment analysis for Pharma Mar S.A.. For live market cap and broader valuation context, see PHM market cap.

Year	Reinvestment Rate	Total Reinvested (EUR)	Operating CF	Capex	YoY Change
2025	1.24x	€65.69 Million	€53.13 Million	€9.38 Million	▼ -55.0%
2024	2.74x	€16.54 Million	€6.03 Million	€15.51 Million	▲ +433.1%
2022	0.51x	€19.73 Million	€38.32 Million	€8.85 Million	▼ -61.2%
2021	1.33x	€34.08 Million	€25.68 Million	€7.80 Million	▲ +211.1%
2020	0.43x	€119.01 Million	€278.94 Million	€3.00 Million	▼ -83.2%
2015	2.55x	€28.26 Million	€11.10 Million	€9.22 Million	▲ +144.8%
2014	1.04x	€22.99 Million	€22.11 Million	€10.18 Million	▲ +421.6%
2013	0.20x	€3.26 Million	€16.34 Million	€2.10 Million	▼ -37.9%
2012	0.32x	€2.03 Million	€6.32 Million	€2.03 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow